NASDAQ:HRTX

Heron Therapeutics Stock Predictions

etoro logo Buy HRTX
*Your capital is at risk
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HRTX Prediction Chart

HRTX Predictions History

Latest community submissions for HRTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 10, 2025 $2.07 -2.34% $2.12 X 97.66% 0
Jun 10, 2025 $2.09 -1.46% $2.12 X 98.54% 1
Jun 10, 2025 Bullish $2.12 X 0
May 8, 2025 $2.33 +3.28% $2.17 X 92.44% 0
May 8, 2025 $2.31 +2.05% $2.17 X 93.72% 0
May 8, 2025 Bullish $2.17 X 0
Mar 7, 2025 $2.44 +3.20% $2.39 V 98.10% 1
Mar 7, 2025 $2.31 -2.00% $2.39 X 96.77% 0
Mar 7, 2025 Bullish $2.39 X 1
Feb 10, 2025 $1.77 +1.59% $1.68 X 94.79% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HRTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE